1. Home
  2. VYGR vs MFH Comparison

VYGR vs MFH Comparison

Compare VYGR & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • MFH
  • Stock Information
  • Founded
  • VYGR 2013
  • MFH 2011
  • Country
  • VYGR United States
  • MFH United States
  • Employees
  • VYGR N/A
  • MFH N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • MFH Finance: Consumer Services
  • Sector
  • VYGR Health Care
  • MFH Finance
  • Exchange
  • VYGR Nasdaq
  • MFH Nasdaq
  • Market Cap
  • VYGR 342.5M
  • MFH 394.2M
  • IPO Year
  • VYGR 2015
  • MFH N/A
  • Fundamental
  • Price
  • VYGR $5.22
  • MFH $6.97
  • Analyst Decision
  • VYGR Strong Buy
  • MFH
  • Analyst Count
  • VYGR 9
  • MFH 0
  • Target Price
  • VYGR $15.53
  • MFH N/A
  • AVG Volume (30 Days)
  • VYGR 361.6K
  • MFH 127.0K
  • Earning Date
  • VYGR 02-26-2025
  • MFH 12-05-2024
  • Dividend Yield
  • VYGR N/A
  • MFH N/A
  • EPS Growth
  • VYGR N/A
  • MFH N/A
  • EPS
  • VYGR 0.47
  • MFH N/A
  • Revenue
  • VYGR $163,784,000.00
  • MFH $716,863.00
  • Revenue This Year
  • VYGR N/A
  • MFH N/A
  • Revenue Next Year
  • VYGR N/A
  • MFH N/A
  • P/E Ratio
  • VYGR $11.19
  • MFH N/A
  • Revenue Growth
  • VYGR 3.40
  • MFH 119.50
  • 52 Week Low
  • VYGR $4.99
  • MFH $1.03
  • 52 Week High
  • VYGR $10.66
  • MFH $8.86
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 38.79
  • MFH 55.53
  • Support Level
  • VYGR $4.99
  • MFH $6.50
  • Resistance Level
  • VYGR $5.45
  • MFH $8.86
  • Average True Range (ATR)
  • VYGR 0.26
  • MFH 0.91
  • MACD
  • VYGR -0.05
  • MFH 0.01
  • Stochastic Oscillator
  • VYGR 17.97
  • MFH 45.38

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About MFH Mercurity Fintech Holding Inc.

Mercurity Fintech Holding Inc is a digital fintech company powered by blockchain technology. The company's scope of business includes digital asset trading, asset digitization, cross-border remittance, and other services, providing compliant, professional, and efficient digital financial services to its customers. The group is also engaged in Bitcoin mining, digital currency investment, and trading, continuing its expansion to online and traditional brokerage services and other related fields.

Share on Social Networks: